Iron-sulfur (Fe-S) proteins are key players in vital processes involving energy homeostasis and metabolism from the simplest to most complex organisms. We report a 1.5 Å x-ray crystal structure of the first identified outer mitochondrial membrane Fe-S protein, mitoNEET. Two protomers intertwine to form a unique dimeric structure that constitutes a new fold to not only the Ϸ650 reported Fe-S protein structures but also to all known proteins. We name this motif the NEET fold. The protomers form a two-domain structure: a ␤-cap domain and a cluster-binding domain that coordinates two acid-labile 2Fe-2S clusters. Binding of pioglitazone, an insulin-sensitizing thiazolidinedione used in the treatment of type 2 diabetes, stabilizes the protein against 2Fe-2S cluster release. The biophysical properties of mitoNEET suggest that it may participate in a redox-sensitive signaling and/or in Fe-S cluster transfer. diabetes ͉ FeS cluster ͉ iron homeostasis ͉ thiazolidinedione ͉ oxidative stress I ron (Fe) is a vital trace element for virtually all organisms. Incorporation of this transition metal into iron-sulfur (Fe-S) clusters forms cofactors integral to diverse biological pathways involved in the capture and metabolism of light and chemical energy (1, 2). Because free iron can be highly toxic, an elaborate array of proteins has evolved to facilitate the transfer of iron through cell compartments, to insert iron into Fe-S clusters, and to incorporate Fe-S clusters into proteins. Fe-S cluster assembly takes place primarily, although not exclusively, within the mitochondrial matrix of eukaryotic cells, and defects in mitochondrial cluster assembly and export have profound consequences for rates of growth, iron accumulation, oxidative stress, and heme biosynthesis (1, 2).
I
ron (Fe) is a vital trace element for virtually all organisms. Incorporation of this transition metal into iron-sulfur (Fe-S) clusters forms cofactors integral to diverse biological pathways involved in the capture and metabolism of light and chemical energy (1, 2) . Because free iron can be highly toxic, an elaborate array of proteins has evolved to facilitate the transfer of iron through cell compartments, to insert iron into Fe-S clusters, and to incorporate Fe-S clusters into proteins. Fe-S cluster assembly takes place primarily, although not exclusively, within the mitochondrial matrix of eukaryotic cells, and defects in mitochondrial cluster assembly and export have profound consequences for rates of growth, iron accumulation, oxidative stress, and heme biosynthesis (1, 2) .
Mitochondrial dysfunction is associated with insulin resistance and the development of type 2 diabetes (3). Recent studies suggest that disease pathogenesis involves diminished mitochondrial oxidative capacity in insulin-sensitive tissues. Pharmacologic agents extensively used to treat insulin resistance such as the thiazolidinedione (TZD) pioglitazone are known to enhance oxidative capacity and normalize lipid metabolism (4, 5) . Although TZDs are conventionally thought to operate through binding to peroxisome proliferator-activated receptors, a recent study by Colca and colleagues (6) identified an additional binding target within mitochondrial membranes that was named mitoNEET, on the basis of the subcellular localization (mito) and the presence of the amino acid sequence Asn-Glu-Glu-Thr (NEET).
MitoNEET was determined to be an integral protein of the outer mitochondrial membrane (OMM) by a series of studies, including immuno-electron microscopy and detailed fractionation studies of highly purified rat liver mitochondria. An amino-terminal signal sequence within the first 32 residues, containing a predicted transmembrane domain, targets mitoNEET to the outer membrane. The orientation of this protein toward the cytoplasm was established by proteolytic digestion of this protein on intact rat liver mitochondria. Deficiency of this protein in mice results in a compromise in the respiratory capacity of heart mitochondria (7) .
MitoNEET belongs to an ancient family of proteins for which the hallmark is the presence of a unique 39-aa CDGSH domain
Although currently annotated as a zinc finger moiety in the NCBI protein database (8), the CDGSH domain actually binds a 2Fe-2S cluster. As such, mitoNEET is the first identified 2Fe-2S cluster containing protein located on the OMM (7, 9) . The absorption spectrum has a peak near 460 nm attributed to the 2Fe-2S cluster that is reversibly reduced by dithionite and oxygen. The cluster is labile at pH Յ8.0, as shown by the loss of the spectral signature and of the 2Fe and 2S as shown by mass spectroscopy (9) . We report that this novel OMM protein folds into a unique homodimeric structure with one 2Fe-2S cluster bound to each protomer within the dimer determined by x-ray crystallography using multiwavelength anomalous dispersion (MAD) phasing.
Results
The Overall Unique Structure and Domain Topology of MitoNEET. In an effort to understand the structural properties of this protein, we produced a soluble form of recombinant human mitoNEET corresponding to amino acids 33-108 (lacking the aminoterminal targeting and transmembrane sequences) for structural analysis. The isolated recombinant protein crystallized in the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a ϭ 46.81 Å, b ϭ 49.62 Å, c ϭ 59.01 Å. The Matthews coefficient (V m ) of the crystal was 1.9 Å 3 /Da with an estimated solvent content of 33%.
We determined the crystal structure of mitoNEET by MAD phasing (10) . X-ray diffraction intensities were collected at Stanford Synchrotron Radiation Laboratory (SSRL) BL9-2 to a resolution of 1.8 Å at three wavelengths corresponding to the inflection, absorp-tion peak, and high energy remote. X-ray diffraction data from a second crystal were collected to an enhanced resolution of 1.5 Å for refinement of the atomic coordinates ( Table 1) . The model was refined to an R-factor of 18.2% (R free ϭ 22.2%). The high quality of the electron density is shown in Fig. 1 A. The refined model reveals a parallel homodimeric structure that includes the cytoplasmic fragment of each protomer from Lys-42 to Lys-106 on Protomer A and from Ala-43 to Glu-107 on Protomer B of the dimer (Fig. 1 A) . The homodimer is tightly packed with 2,020 Å 2 of buried surface area at the interface. Model validation using the MOL-PROBITY (12) structure validation tool indicates that 96.8% of the amino acid residues are in the favored region of ⌽/⌿ space.
Each protomer is composed of a helical turn (Met-62-Asp-64), an alpha helix (Ala-86-Thr-94), an anti-parallel ␤-structure (Lys-68-Tyr-71, Leu-101-Lys-104), an additional ''swapping'' strand (Ile-56-Asp-61), and 11 interconnecting ␤-turns and loops (Fig. 1) . The protein is folded into two spatially distinct subregions: a ␤-rich or ''␤-cap'' domain and a helical 2Fe-2S binding or ''clusterbinding'' domain (Fig. 1B) . Fig. 1 provides a detailed topological analysis of each of these domains. The ␤-rich domain contains a strand swap from opposite ends of the primary sequence to form the ␤-cap structure (Fig. 1B) . This domain contains 28 residues within ␤-strands with residues Ile-56-Asp-61 from Protomer A and Lys-68-Tyr-71 and Leu-101-Lys-104 from Protomer B making one three-stranded sheet, and with Ile-56-Asp-61 from Protomer B and Lys-68-Tyr-71 and Leu-101-Lys-104 from Protomer A making the second ␤-sheet (Fig. 1B) . These two strand-swapped sheets pack together to form the ␤-cap domain and form the narrowest end (15 Å across) of the structure (Fig. 1B) . The swapped regions come from opposite ends of the primary sequence (Fig. 1C) . A prominent feature of the structure is the presence of two 2Fe-2S clusters that are separated by Ϸ16 Å from each other within the larger helical cluster-binding domain (Ϸ30 Å across) (Fig. 1B) . The N termini protrude from the bottom of the cluster-binding domain and link to the membrane-spanning sequence (data not shown) in the fulllength protein, orienting this domain close to the OMM. A structural similarity search using the DALI server (13) revealed that this fold is novel when compared with the Ͼ650 known Fe-S proteins, and it is also unique when compared with the Ͼ44,200 known members of the structural databases. Hence we term this structural class the NEET fold.
The Buried Interface Is Unusual in MitoNEET. Molecular representations of mitoNEET are shown in Fig. 2 and highlight the packing of hydrophobic and charged residues. In Fig. 2 A we show two orientations of the structure. The hydrophobic/aromatic residues predominantly cluster in the center of the molecule and stabilize the individual protomers (Fig. 2B ). Charged residues cluster at the top of the ␤-cap domain and at the 2Fe-2S cluster-binding domain (Fig.  2C ). This distribution creates a dimer that is polar at the top and bottom separated by a hydrophobic region. An interesting asymmetry of charge is located within the interior of the protein forming a macrodipole with the negative end at the top of the ␤-cap domain and the positive end within the cluster-binding domain, formed by an unexpected interprotomer hydrogen bond between His-58 and Arg-73 located near the cluster (Figs. 2C and 3) . Interestingly, the conserved Arg-73 is located directly between the Cys ligands of the innermost Fe of the cluster (Fig. 3 ). This interaction stabilizes the dimer interface. Separating the poles of the dipole are the hydrophobic residues that form a ring around the two protomers within the dimer (Fig. 2B) . The hydrophobic nature of this area may play a role in flexibility and mobility in the vicinity of the 2Fe-2S cluster contributing to its binding and release.
The 2Fe-2S Cluster Cradle. The sequences Lys-42-Lys-55 and Cys-72-Asn-97 on each protomer comprise the cluster-binding domain ( Fig. 1 B and D) . Within the cluster-binding domain, the polypeptide backbone chain from Cys-72-Gly-85 folds into a coil that contains the three coordinating Cys ligands-Cys-72, Cys-74, and Cys-83-and cradles the 2Fe-2S cluster (Fig. 3) . The fourth ligand (12, 31) . Rsym ϭ ¥Ii Ϫ ͗Ii͘/¥Ii, where Ii is the scaled intensity of the ith measurement and ͗Ii͘ is the mean intensity for that reflection. Rcryst ϭ ¥ Fobs Ϫ Fcalc /¥Fobs, where Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively. Rfree ϭ Rcryst, but for 5.0% of the total reflections chosen at random and omitted from refinement. *Highest-resolution shell in parentheses. † Typically, the number of unique reflections used in refinement is less than the total number that were integrated and scaled. Reflections are excluded due to systematic absences, negative intensities, and rounding errors in the resolution limits and cell parameters.
for the 2Fe-2S cluster (His-87) lies at the N terminus of the ␣-helix within cluster-binding domain Ala-86-Thr-94. Interestingly, mitoNEET shares this unusual 3Cys cluster coordination with the structurally unrelated cluster scaffold protein IscU (14, 15) . The 3Cys-1His coordination seen here is in agreement with the conclusions of previous solution studies of mitoNEET (9) . Cys-83 and His-87 are solvent-accessible and coordinate to the outermost Fe, whereas Cys-72 and Cys-74 coordinate the innermost Fe of the 2Fe-2S cluster (Fig. 3) . The binding coils, one from each protomer, protrude away from the core of the dimer and the noncrystallographic dyad axis (Fig. 1 A) . We predict that the cluster-binding domain, and specifically the C terminus of each ␣-helix is situated near the OMM in vivo.
Pioglitazone Stabilizes the 2Fe-2S Cluster. Pioglitazone, a member of the TZD class of insulin-sensitizer drugs (16) (17) (18) , binds to mitoNEET in vitro as demonstrated by photoaffinity labeling (6) . In an effort to observe the effects of pioglitazone binding on the protein stability of mitoNEET, we followed the characteristic absorbance of the 2Fe-2S cluster at 460 nm as a function of time at pH 6.0 under conditions known to lead to cluster release (9) . The presence of pioglitazone (stoichiometric to the total 2Fe-2S cluster concentration) increased the stability by Ϸ10-fold compared with the control sample lacking pioglitazone [ Fig. 4A and supporting information (SI) Fig. 6 ]. In addition, two-dimensional homonuclear NMR methods (19) demonstrated that, although the overall structure of the protein remains intact upon drug binding, chemical shift changes are observed in the aromatic and aliphatic resonances. NMR resonance(s) of the ring protons of aromatic residues shift and exhibit new through-space couplings upon addition of pioglitazone (Fig. 4B) . In addition, the amide and ring nitrogen protons of the Tyr-71 and Trp-75 residues are stabilized, leading to slower hydrorogen/deuterium exchange rates (data not shown).
Discussion
Although Ͼ650 structures of Fe-S-containing proteins are currently available, the structure of mitoNEET presented here is unique among all known structures (Ͼ44,200 structures currently). The 2Fe-2S cluster of recombinant mitoNEET is reversibly reduced/oxidized at pH 8.0 (Fig. 5) , consistent with a function for mitoNEET that involves electron transfer. Such functions could include redox reactions with metabolic intermediates, cofactors, and/or proteins localized at the OMM. As mitoNEET regulates maximal respiratory capacity in mouse heart mitochondria (7), it is possible that the protein acts as a sensor, adjusting oxidative capacity through participation in a redox-sensitive signaling pathway.
As intriguing is the unusual lability of the 2Fe-2S clusters in mitoNEET at pH Յ8, attributed to the protonation of the coordinating ligand His-87 (9); His-87 cannot serve as a stabilizing ligand for the 2Fe-2S when protonated. His-87 resides at the N terminus of the helical sequence AHTKHNEET that is predicted to have only marginal helical content in solution (20) but is likely stabilized by cluster binding. Conversely, protonation of the His-87 could destabilize the helix, facilitating cluster release/transfer. A second histidine (His-58) that forms an unusual interprotomer hydrogen bond with Arg-73 (Fig. 3) is also located near the cluster. Disruption of this hydrogen bond would weaken the interprotomer interaction. Because Arg-73 is located sequentially between the Cys ligands of the innermost Fe of the cluster (Fig. 3) , perturbation of its inter- action with His-58 will likely lead to reorientation of the inner sphere Cys ligands, potentially providing additional conformational control of binding. Below pH 8 in vitro, the 2Fe-2S cluster is labile; the 2Fe-2S cluster is less stable at physiological pH than other 2Fe-2S proteins (9) . Modulation of the destabilization/stabilization of cluster binding in vivo could be achieved under physiological conditions upon docking of another protein, providing a convenient trigger for controlling cluster release.
This unusual characteristic of the protein raises the interesting possibility that mitoNEET participates in Fe-S cluster assembly, potentially facilitating cluster shuttling between proteins in the mitochondria and cytoplasm. Proteins that act as scaffolds for Fe-S cluster assembly are within the mitochondrial matrix and cytoplasm of yeast and mammalian cells, although matrix synthesis is believed to predominate (14, 21) . Although several proteins involved in the export of clusters synthesized in the mitochondrial matrix have been identified in yeast (1, 22) , the mechanism by which clusters are transported across the OMM and shuttled to cytosolic apoproteins in yeast and in higher organisms is unknown. MitoNEET is uniquely positioned to possibly receive and then transfer a cluster that has crossed the outer membrane, or alternately may serve as a Fe-S cluster reservoir or storage protein (Fig. 5) .
Pioglitazone is a highly hydrophobic molecule that is largely bound to serum albumin after patient ingestion and before cellular uptake and binding to its intracellular targets (23) . In addition to hydrophobic interactions, our data indicate that binding of pioglitazone increases stability of the 2Fe-2S cluster and of hydrogen bonding interactions within the protein. Taken together with the unique distribution of hydrophobic residues in the dimer (Fig. 2B) , our structural results may have important implications for both mechanisms of drug action and future optimization of TZDs.
Although these compounds activate peroxisome proliferatoractivating receptors, data suggesting alternative modes of action involving mitochondria has accumulated (24) . Whether the beneficial effects of TZDs on mitochondria including biogenesis and normalization of lipid oxidation (4, 5) are mediated through mitoNEET is unknown. However, these data, combined with those of Colca et al. (6) , suggest that pioglitazone can bind and alter the properties of mitoNEET that is expressed in many insulinresponsive tissues (7) . Although further biological and biophysical experiments are needed to relate in vitro binding to in vivo effects, mitoNEET may prove to be an alternative target for drug actions.
Materials and Methods

Construction of Bacterial Expression Plasmid and Purification of
MitoNEET. The portion of the human mitoNEET cDNA corresponding to amino acids 33-108 was amplified by PCR and cloned into the pet21aϩ vector. Expression in BL21-CodonPlus-RIL and purification was as described (9) with the time after induction extended to 18 h at 22°C. We included an additional cation exchange chromatography step using HiTrap (GE Healthcare) to achieve crystal-quality purification. The purified material had a peak centered at 458 nm and an optical ratio (A 278 /A 458 ) of 2.3-2.4 under these buffer conditions. Optical spectra were measured on a Cary50 spectrometer (Varian, Walnut Creek, CA). (Fig. 2C ).
2Fe-2S centers (7.5 M dimeric mitoNEET ϭ 15 M monomeric mitoNEET) were measured in 200 mM phosphate-HCl (pH 7.5) with and without stoichiometric (Ϯ10%) pioglitazone (25°C). The stability of the 2Fe-2S clusters was determined from monitoring their characteristic absorbance at 460 nm ( max at pH 6.0) as a function of time (9) . Measurements performed in the NMR buffer (50 mM potassium phosphate/50 mM sodium chloride/5 mM Tris, pH 7.8) gave the same results. The measured pH was the same at the beginning and end of each experiment. Control experiments with equal volume addition of 0.1 M HCl did not change the solution pH (Ϯ0.01 units) nor alter the physical and spectral properties (Ϯ2%) of the protein. Ten microliters of pioglitazone was added in 1-l incremental amounts to 450 l of mitoNEET sample. This step was necessary to avoid locally high acidic spots that would destabilize the 2Fe-2S cluster. Following temperature equilibration, NMR spectra were acquired at 36°C by using Bruker DMX 500 MHz and Bruker DRX 600 MHz spectrometers. Homonuclear 1 H 2D NOESY spectra were acquired with a mixing time of 400 ms. Spectral processing was performed by using Felix Software (Accelrys, San Diego, CA).
Crystallization. Initial crystallization screening was performed both in house and at Hauptman-Woodward Institute (Buffalo, New York). Screens were attempted around initial conditions that yielded crystals. Our final conditions were 100 mM Tris⅐HCl (pH 8), 100 mM NaCl , and 30-32% PEG 3000 in the reservoir. Samples were frozen (77 K) after a 1-min soak in 100 mM Tris⅐HCl (pH 8), 40% PEG3000 and sent frozen (77 K) to SSRL in an SSRLsupplied cassette system for data collection and analysis.
X-Ray Diffraction. Frozen crystals were screened by using the Stanford Automated Mounter (25) operated by Blu-Ice (26) . The data were recorded on a 325-mm Marmosaic CCD detector. Data sets were collected from two crystals. A 1.5 Å resolution data set, used for structure refinement, was collected at SSRL BL11-1 from a 0.9-ϫ 0.075-ϫ 0.075-mm crystal. Data were collected from two locations on opposite ends of this crystal by using a 0.1-ϫ 0.075-mm beam size. A three-wavelength Fe-MAD data set, used for initial phasing, was collected at SSRL BL9-2 from a 1.0-ϫ 0.2-ϫ 0.1-mm crystal. The wavelengths for data collection were selected by using a plot of fЈ and fЉ calculated with the program CHOOCH (27) from the x-ray fluorescence spectrum of the crystal. A total of 360°were MitoNEET is shown linked (magenta and green) to the OMM (gray) (not to scale). On the basis of mitoNEET biophysical properties, two possible functions are suggested: cluster transfer (blue arrows) and electron transfer (wine arrows). Right side (wine), our previous results (9) showed that the 2Fe-2S cluster could be reduced (1Ј) and reoxidized (2Ј) (Ϫ0.3 V Յ Em Յ 0.1 V). Left side, previous and current results showed that upon protonation of His-87 (1), the 2Fe-2S cluster dissociates from the protein (2) . We here propose that the changes in the interaction of His-87 with the cluster are likely related to its function. In vivo this interaction may be broken by docking of another protein, thereby providing a convenient trigger for cluster release. Binding of pioglitazone to mitoNEET (Fig. 4) increases the stability of the 2Fe-2S cluster, thereby inhibiting release of the cluster.
collected at each wavelength following the inverse-beam method with a wedge size of 30°. All data were processed with XDS (28).
Structural Determination. The structure of mitoNEET was determined by MAD phasing (10, 29 (32) . Several rounds of automated model-building and refinement were implemented by using ARP/wARP (33) , which resulted in significantly improved electron density maps and placement of 97-aa sidechains into electron density.
The data from several independent sets were processed by using an automated script developed by Qingping Xu at the Joint Center for Structural Genomics (JCSG, SSRL) that runs XDS (28) . Model completion and refinement were performed in COOT (34) and REFMAC5 (35) , respectively. Analyses of the stereochemical quality of the models were accomplished by using an automated validation server developed by Chris Rife at the JCSG (SSRL) implementing MolProbity (12) , ADIT (36) , and WHATIF 5.0 (37) . Structural figures were rendered with PyMol (11) .
